Figure 2

Changes in central retinal thickness (CRT) for tAMD and PCV patients after intravitreal ranibizumab. Diamonds with solid lines: tAMD; Squares with dashed lines: PCV. Values represent means ± SEM.
Changes in central retinal thickness (CRT) for tAMD and PCV patients after intravitreal ranibizumab. Diamonds with solid lines: tAMD; Squares with dashed lines: PCV. Values represent means ± SEM.